This section contains references to information on clinical trials related to carcinoid cancer and neuroendocrine tumors. This section may not represent an inclusive list of all clinical trials that are in process or being planned worldwide.

The U.S. National Institutes of Health, through its National Library of Medicine, has developed ClinicalTrials.gov to provide patients, family members and members of the public current information about clinical research studies.

For additional clinical trials contact the NCI’s Cancer Information service at 800-422-6237


STARTRK-2: A Basket Trial for Neuroendocrine Tumor Patients with Specific Gene Rearrangements

Precision medicine, molecular testing, basket studies, STARTRK-2 – it may sound like technology of the future but it is here today and it might be the answer to slowing or stopping tumor growth for neuroendocrine tumor (NET) patients who have specific gene rearrangements.

Read more about the trial here: https://www.carcinoid.org/2017/04/07/startrk-2-basket-trial-neuroendocrine-tumor-patients-specific-gene-rearrangements/


Please also visit North American NeuroEndocrine Tumor Society (NANETS) for current clinical trials information: https://www.nanets.net/content/current-clinical-trials

 

Health Familial Carcinoid Cancer Study: Natural History of Familial Carcinoid Tumor

This study is currently recruiting participants. Verified by National Institutes of Health Clinical Center (CC), September 2016

Article published in Gastroenterology in 2015:

A Hereditary Form of Small Intestinal Carcinoid Associated with a Germline Mutation in Inositol Polyphosphate Multikinase

Information from the NIH:

NIH Study Finds Genetic Link for Rare Intestinal Cancer

Do You Understand Clinical Trials?  Excellent, short video from the European Patients’ Academy (EUPATI). Read more and watch the video

Print Friendly